Risposta mantenuta al trattamento di seconda linea con sacituzumab govitecan in paziente con malatti...
Risposta mantenuta al trattamento di seconda linea con sacituzumab govitecan in paziente con malattia encefalica e sistemica da TNBC
About this item
Full title
Author / Creator
Publisher
Rome: Pensiero Scientifico Editore
Journal title
Language
Italian
Formats
Publication information
Publisher
Rome: Pensiero Scientifico Editore
More information
Scope and Contents
Contents
The higher frequency of metastasization and poor prognosis of triple-negative breast cancer require suitable expertise in order to set up an appropriate and effective treatment plan for these patients. Our case describes the clinical history of a 63-year-old BRCA1/2 wild-type woman with excellent ECOG performance status and advanced PD-L1 negative...
Alternative Titles
Full title
Risposta mantenuta al trattamento di seconda linea con sacituzumab govitecan in paziente con malattia encefalica e sistemica da TNBC
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_3174415725
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3174415725
Other Identifiers
ISSN
0034-1193
E-ISSN
2038-1840
DOI
10.1701/4274.42537
